Literature DB >> 21790279

Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?

Maurizio Cutolo, Alberto Sulli, Vanessa Smith.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21790279     DOI： 10.1586/eci.11.35

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

1.  Nailfold capillaroscopy assessment of microcirculation abnormalities and endothelial dysfunction in children with primary or secondary Raynaud syndrome.

Authors:  Joanna Latuskiewicz-Potemska; Antonina Chmura-Skirlinska; Ryszard J Gurbiel; Elzbieta Smolewska
Journal:  Clin Rheumatol       Date:  2016-06-29       Impact factor: 2.980

2.  Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil.

Authors:  Predrag Ostojic
Journal:  Rheumatol Int       Date:  2012-12-28       Impact factor: 2.631

3.  Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.

Authors:  Hèctor Corominas; Vera Ortiz-Santamaría; Iván Castellví; Mireia Moreno; Rosa Morlà; Teresa Clavaguera; Alba Erra; Silvia Martínez-Pardo; Sergi Ordóñez; Pilar Santo; Patricia Reyner; Maria José González; Oriol Codina; Mario Saul Gelman; Xavier Juanola-Roura; Alex Olivé; Vicenç Torrente-Segarra
Journal:  Rheumatol Int       Date:  2015-11-23       Impact factor: 2.631

Review 4.  Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated?

Authors:  Mahnaz Etehad Tavakol; Alimohammad Fatemi; Abdolamir Karbalaie; Zahra Emrani; Björn-Erik Erlandsson
Journal:  Biomed Res Int       Date:  2015-09-01       Impact factor: 3.411

5.  Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis.

Authors:  Jérôme Avouac; Maeva Vallucci; Vanessa Smith; Patricia Senet; Barbara Ruiz; Alberto Sulli; Carmen Pizzorni; Camille Frances; Gilles Chiocchia; Maurizio Cutolo; Yannick Allanore
Journal:  Arthritis Res Ther       Date:  2013-04-19       Impact factor: 5.156

6.  Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.

Authors:  Claudio Corallo; Maurizio Cutolo; Bashar Kahaleh; Gianluca Pecetti; Antonio Montella; Chiara Chirico; Stefano Soldano; Ranuccio Nuti; Nicola Giordano
Journal:  Arthritis Res Ther       Date:  2016-10-06       Impact factor: 5.156
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.